Диссертация (1139859), страница 20
Текст из файла (страница 20)
M., Sivrioglu E. Y., Salzman C. 15 Pharmacotherapy of Late-Life Depression: Evidence-Based Recommendations //Mood disorders in later life. –2008. – С. 239.108.Enache D, Winblad B, Aarsland D. Depression in dementia:epidemiology, mechanisms, and treatment. Curr Opin Psychiatry 2011;24:461–72.114109. Everson S.A., Roberts R.E., Goldberg D.E. et al. Depressive symptoms andincreased risk of stroke mortality over a 29 year period. Arch Intern Med1998;158(10):1133–8.110.Finkel SI, Richter EM, Clary CM.
Comparative efficacy and safety ofsertraline versus nortriptyline in major depression in patients 70 and older. IntPsychogeriatr, 1999 Mar 11:85-99.111.Fiske A., Wetherell J. L., Gatz M. Depression in older adults //Annualreview of clinical psychology. – 2009. – Т. 5. – С.
363-389.112.Flint AJ. Choosing appropriate antidepressant therapy in the elderly. Arisk-benefit assessment of available agents. Drugs Aging, 1998 Oct; 13(4): 269-80.113.Gallagher D. et al. Late life depression: a comparison of risk factors andsymptoms according to age of onset in community dwelling older adults //Internationaljournal of geriatric psychiatry. – 2010. – Т. 25.
– №. 10. – С. 981-987.114.Gallo J.J., Rabins P.V. Depression without sadness — alternativepresentation of depression in late life. Am Family Phisicion 1999; 60(3):11-23.115. Gasser A. I., Salamin V., Zumbach S. Late life depression or prodromalAlzheimer's disease: Which tools for the differential diagnosis? //L'Encephale. – 2017.S0013-7006(17)30086-6.116. Glatzel J. Endogene Depressionen.
2 Uberarbeitete und erweiterte Auflage.Stuttgart 1982; 222.117. Goldberg D., Fawcett J. The importance of anxiety in both major depressionand bipolar disorder //Depression and anxiety. – 2012. – Т. 29. – №. 6. – С. 471-478.118. Guelfi JD, Bouhassira M; Bonett-Perrin E; Lancrenon S. The study of theefficacy of fluoxetine versus tianeptine in the treatment of elderly depressed patientsfollowed in general practice. Encephale, 1999 May-Jun; 25(3): 265-70.119. Gutzmann H., Krüger H., Neumann E.
M. Organic, Including Symptomatic,Mental Disorders (SectionF0)-Results of the ICD-10 Field Trial //Pharmacopsychiatry.– 1990. – Ò. 23. – ¹. S 4. – Ñ. 146-150.120. Hayflick L. Biological aging is no longer an unsolved problem //Annals ofthe New York Academy of Sciences. – 2007. – Т. 1100. – №. 1. – С. 1-13.115121. Henderson AS. The social psychiatry of later life.Br J Psychiatry.
1990May;156:645-53.122. Hybels C. F., Landerman L. R., Blazer D. G. Age differences in symptomexpression in patients with major depression //International journal of geriatricpsychiatry. – 2012. – Т. 27. – №. 6. – С. 601-611.123. Inouye S. K. et al. Geriatric syndromes: clinical, research, and policyimplications of a core geriatric concept //Journal of the American Geriatrics Society. –2007. – Т. 55. – №. 5. – С.
780-791.124. Ismail Z, Malick A, Smith EE, et al. Depression versus dementia: is thisconstruct still relevant? Neurodegener Dis Manage. 2014;4(2):119–26.125. Jacobson S.A., Pies R.W., Katz I.R. Clinical manual of geriatricpsychopharmacology. American Psychiatric Publishing, Inc (Washington, DC London,England) 2007; 17—55126. Jonas B.S., Mussolino M.E. Symptoms of depression as a prospective riskfactor for stroke. Psychosom Med 2000;62:463–71.127. Jorm A.F. Is depression a risk factor for dementia or cognitive decline? Areview. Gerontology 2000;46(4):219–27.128. Jorm A. F.
Is depression a risk factor for dementia or cognitive decline?//Gerontology. – 2000. – Т. 46. – №. 4. – С. 219-227.129. Jorm A.F. цит. Y.Forsell. Depression and Dementia in the Elderly,Stockholm 1994; 54.130. Kanner A.M. Depression in neurological disorders. Lundbec Inst 2005. 161p.131. Kantarci K. et al. 1 H magnetic resonance spectroscopy, cognitive function,and apolipoprotein E genotype in normal aging, mild cognitive impairment andAlzheimer's disease //Journal of the International Neuropsychological Society. – 2002.– Т.
8. – №. 7. – С. 934-942.132.Katona C, Livingston G. How well do antidepressants work in olderpeople? A systematic review of Number Needed to Treat. Journal of AffectiveDisorders, 2002; 69, 47-52.116133. Klysner R. É. et al. Efficacy of citalopram in the prevention of recurrentdepression in elderly patients: placebo-controlled study of maintenance therapy //TheBritish Journal of Psychiatry. – 2002. – Т. 181.
– №. 1. – С. 29-35.134. Köhler S. et al. The pattern and course of cognitive impairment in late-lifedepression //Psychological medicine. – 2010. – Т. 40. – №. 4. – С. 591-602.135. Larson S.L., Owens P.L., Ford D., Eaton W. Depressive disorder dysthymiaand risk of stroke. Therteen year follow-up from the BECAS. Stroke 2001;32:1979–83.136. Lotrich FE, Pollock BG. Aging and clinical pharmacology: implications forantidepressants. J Clin Pharmacol 2005; 45:1106–1122.137. May M., McCarron P., Stansfeld S. et al.
Does psychological distress predictthe risk of ischemic stroke and transient ischemis attack? The Caerphilly Study. Stroke2002;33:7–12.138. Martin RM, Hilton SR, Kerry SM, Richards NM. General practitioners'perceptions of the tolerability of antidepressant drugs: a comparison of selectiveserotonin reuptake inhibitors and tricyclic antidepressants. BMJ 1997; 314: 646-651.139. Mayou R. et al. Somatoform disorders: time for a new approach in DSM-V//American Journal of Psychiatry. – 2005. – Т.
162. – №. 5. – С. 847-855.140. Modrego PJ. Depression in Alzheimer's disease. Patho-physiology,diagnosis, and treatment. J Alzheimers Dis 2010;21:1077–87.141. Mukai Y, Tampi RR. Treatment of depression in the elderly: a review of therecent literature on the efficacy of single- versus dual-action antidepressants. Clin Ther.2009 May; 31(5):945-61142. Muller-Spahn F.,Hock C. Int.J.Experimental and Clinical Gerontology 1994;(suppl 1): 5-9.143. Mulsant BH, Sweet RA, Rosen J, et al. A double-blind randomizedcomparison of nortriptyline plus perphenazine versus nortriptyline plus placebo in thetreatment of psychotic depression in late life.
J Clin Psychiatry, 2001, Aug; 62(8):597604144. Murphy E. Depression im Alter (225-251) In: Alterspsychiatrie, Psychiatrieder Gegenwart 8. Berlin 1989; 418.117145. Nelson JC, Delucchi K, Schneider LS. Efficacy of second generationantidepressants in late-life depression: a meta-analysis of the evidence. Am J GeriatrPsychiatry, July 2008; 16:558-567146. Novais F, Starkstein S. Phenomenology of depression in Alzheimer'sdisease. J Alzheimers Dis 2015;47:845–55.147.
Olin JT, Schneider LS, Katz IR et al. Provisional diagnostic criteria fordepression of Alzheimer's disease. Am J Psychiatry 2002;10:125–8. [PubMed]148. Orgeta V, Qazi A, Spector AE et al. Psychological treatments for depressionand anxiety in dementia and mild cognitive impairment. Cochrane Database Syst Rev2014;1:CD009125149. Ownby RL, Crocco E, Acevedo A, et al. Depression and risk for Alzheimerdisease: systematic review, meta-analysis, and metaregression analysis.
Arch GenPsychiatry. 2006;63(5):530–38.150. Panza F. et al. Impact of depressive symptoms on the rate of progression todementia in patients affected by mild cognitive impairment. The Italian LongitudinalStudy on Aging //International journal of geriatric psychiatry. – 2008. – Т.
23. – №. 7. –С. 726-734.151. Parker G. et al. The differential impact of age on the phenomenology ofmelancholia //Psychological medicine. – 2001. – Т. 31. – №. 7. – С. 1231-1236.152. Petrovic M, De Paepe P, Van Bortel L. Pharmacotherapy of depression inold age. Acta Clin Belg. 2005 May-Jun;60(3):150-156.153. Piet J., Hougaard E. The effect of mindfulness-based cognitive therapy forprevention of relapse in recurrent major depressive disorder: a systematic review andmeta-analysis //Clinical psychology review.
– 2011. – Т. 31. – №. 6. – С. 1032-1040.154. Pirkis J. et al. The community prevalence of depression in older Australians//Journal of affective disorders. – 2009. – Т. 115. – №. 1. – С. 54-61.155. Pollack M. H. Comorbid anxiety and depression //The Journal of clinicalpsychiatry. – 2005. – Т. 66.
– С. 22-29.118156. Pollock B. G., Forsyth C. E., Bies R. R. The critical role of clinicalpharmacologyingeriatricpsychopharmacology//CliniCalpharmaCology&TherapeuTiCs. – 2009. – Т. 85. – №. 1. – С. 89-93.157. Polyakova M, Sonnabend N, Sander C et al. Prevalence of minor depressionin elderly persons with and without mild cognitive impairment: a systematic review.
JAffect Disord 2014;152–154:28–38.158. Popkin S.J., Gallagher D., Thompson L., Moore M. Exp Ageing Res 1982;8: 141-145.159.Rao R. Cerebrovascular diseases and late life depression: an oldassociation revisited . Int JGeriatr Psychiatry 2000;15(5):419–33.160.Reynolds C. F., MA Dew, LM Martire et al. Treating depression toremission in older adults: a controlled evaluation of combined escitalopram withinterpersonal psychotherapy versus escitalopram with depression care management//International journal of geriatric psychiatry. – 2010. – Т.
25. – №. 11. – С. 1134-1141.161.Richardson T. M. et al. Anxiety and its correlates among older adultsaccessing aging services //International journal of geriatric psychiatry. – 2011. – Т. 26.– №. 1. – С. 31-38.162.Rojas-Fernandez C, Thomas VS, Carver D, Tonks R. Suboptimal use ofantidepressants in the elderly: a population-based study in Nova Scotia. Clin Ther 1999Nov 21:1937-50.163. Rossini D. et al. Sertraline versus fluvoxamine in the treatment of elderlypatients with major depression: a double-blind, randomized trial //Journal of clinicalpsychopharmacology. – 2005. – Т. 25. – №. 5. – С. 471-475.164.
Solfrizzi V, D'Introno A, Colacicco AM et al. Incident occurrence ofdepressive symptoms among patients with mild cognitive impairment—the Italianlongitudinal study on aging. Dement Geriatr Cogn Disord 2007;24:55–64.165. Soremekun M. et al. Neurological signs and late‐life depressive symptomsin a community population: the ESPRIT study //International journal of geriatricpsychiatry. – 2010. – Т. 25. – №.
7. – С. 672-678.119166. Sözeri-Varma G. Depression in the elderly: clinical features and risk factors//Aging and disease. – 2012. – Т. 3. – №. 6. – С. 465.167. Shahnawaz Z, Reppermund S, Brodaty H, et al. Prevalence andcharacteristics of depression in mild cognitive impairment: the Sydney Memory andAgeing Study. Acta Psychiatr Scand. 2013;127(5):394–4022. doi: 10.1111/acps.12008.Epub 2012/09/05.168. Vilalta-Franch J, Garre-Olmo J, López-Pousa S et al. Comparison ofdifferent clinical diagnostic criteria for depression in Alzheimer disease. Am J GeriatrPsychiatry 2006;14:589–97.169. Wahlund L.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
